CARGO Therapeutics Common Stock (CRGX)
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: -s
Cancer, Therapies, Treatment, Cell, Therapy, Cancer
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients in the Unites States. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate, which is in phase 2 trails, designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California. Web URL: https://www.cargo-tx.com
Drawdown (Underwater) Chart
CRGX Stock Overview
Market Cap in USD | 941m |
Sector | Healthcare |
Industry | Biotechnology |
GiC SubIndustry | Biotechnology |
TER | 0.00% |
IPO / Inception | 2023-11-10 |
CRGX Stock Ratings
Growth 5y | 5.46 |
Fundamental | - |
Dividend | - |
Rel. Performance vs Sector | 0.37 |
Analysts | 4.67/5 |
Fair Price Momentum | 17.79 USD |
Fair Price DCF | - |
CRGX Dividends
Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
CRGX Growth Ratios
Growth 12m | 39.93% |
Growth Correlation 12m | 25% |
Growth Correlation 3m | -55% |
CAGR 5y | 39.93% |
CAGR/Mean DD 5y | 2.63 |
Sharpe Ratio 12m | 0.57 |
Alpha vs SP500 12m | -11.31 |
Beta vs SP500 5y weekly | 1.90 |
ValueRay RSI | 60.32 |
Volatility GJR Garch 1y | 56.74% |
Price / SMA 50 | -6.71% |
Price / SMA 200 | 0.1% |
Current Volume | 166.8k |
Average Volume 20d | 156.9k |
External Links for CRGX Stock
News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
What is the price of CRGX stocks?
As of May 16, 2024, the stock is trading at USD 20.99 with a total of 166,773 shares traded.
Over the past week, the price has changed by +2.99%, over one month by +5.53%, over three months by -8.02% and over the past year by +39.93%.
As of May 16, 2024, the stock is trading at USD 20.99 with a total of 166,773 shares traded.
Over the past week, the price has changed by +2.99%, over one month by +5.53%, over three months by -8.02% and over the past year by +39.93%.
What is the forecast for CRGX stock price target?
According to ValueRays Forecast Model, CRGX CARGO Therapeutics Common Stock will be worth about 20.3 in May 2025. The stock is currently trading at 20.99. This means that the stock has a potential downside of -3.19%.
According to ValueRays Forecast Model, CRGX CARGO Therapeutics Common Stock will be worth about 20.3 in May 2025. The stock is currently trading at 20.99. This means that the stock has a potential downside of -3.19%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 25.5 | 21.5 |
Analysts Target Price | 25.5 | 21.5 |
ValueRay Target Price | 20.3 | -3.19 |